Advertisement

The demonstration of anti-hypertensive substances in the urine

  • E. Tanner
  • H. Suter
  • J. Conti
  • J. Wanner
Conference paper

Abstract

Medical research constantly gives Man new medicaments which have the capacity to influence anatomical functions and controls in a way previously unsuspected.

Keywords

High Blood Pressure Individual Dose Control Urine Spray Reagent Chloroplatinic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Bäumeler und Rippstein: Pharm. Acta Helv. 36, 382 (1961).Google Scholar
  2. [1a]
    Liebich: Dtsch. Apoth.-Ztg. 99, 1246 (1959);Google Scholar
  3. [1aa]
    Liebich: Dtsch. Apoth.-Ztg. 100, 393 (1960).Google Scholar
  4. [1b]
    Nürnberg: Arch. Pharm. 292/64, 610 (1959).CrossRefGoogle Scholar
  5. Gänshirt: Arch. Pharm. 293/65, 925 (1960).CrossRefGoogle Scholar
  6. [2]
    Dollery, Emslie-Smith and Milne: Lancet (1960), No. 7147, 381.CrossRefGoogle Scholar
  7. [3]
    Experientia 14, 159–160 (1958).Google Scholar
  8. [4]
    Haycock, Sheth, Conolly and Mader: Journal of the association of official agricultural chemists Vol. 42, No. 3, 613 (1959).Google Scholar
  9. [5]
    Korzum, André and Ulshafer: J. Amer. pharm. Ass., sci. Ed. Vol. XLVI, No. 12, 720 (1957).Google Scholar
  10. [6]
    André, Korzum and Weinfeldt: J. org. Chemistry 21, 480 (1956).CrossRefGoogle Scholar
  11. [7]
    Baer, Paulson, Russo and Beyer: Amer. J. Physiol. 186, 180–186 (1956).PubMedGoogle Scholar
  12. [8]
    Zeimis: Brit. J. Pharmacol. 5, 424–430 (1950).Google Scholar
  13. [9]
    Harington: Clin. Sci. 12, 185–198 (1953).PubMedGoogle Scholar
  14. [10]
    Sheppard, Sachs D’Asaro: Nature 177, 1089 (1956).CrossRefGoogle Scholar
  15. [11]
    Perry: J. Lab. clin. Med. 41, 566–573 (1953).PubMedGoogle Scholar
  16. [12]
    Sheppard, Plummer and Sabbagh: Fed. Proc. 15, 483 (1956).Google Scholar
  17. [13]
    Tompsett, Forshall and Smith: Acta pharmacol. (Kbh.) 18, 75–79 (1961).CrossRefGoogle Scholar
  18. [14]
    Rosenheim et al.: Lancet No. 7089, 17 (1959).Google Scholar
  19. [15]
    Haycock, Sheth and Mader: J. Amer. pharm. Ass., sci. Ed. Vol. XLVIII, No. 8, 479 (1959).Google Scholar
  20. [16]
    Sheppard, Wagle and Plummer: Fed. Proc. 13, 404 (1954).Google Scholar
  21. [17]
    Stahl: Pharmazie 11, 633 (1956);PubMedGoogle Scholar
  22. [17a]
    Stahl: Chemiker-Ztg. 82, 323 (1958);Google Scholar
  23. [17b]
    Stahl: Parfumerie u. Kosmet. 9, 564 (1958).Google Scholar
  24. [18]
    Cuzzoni: Pharmaco, ed. pract. 12, 204 (1957).Google Scholar
  25. [18a]
    Bayer: Pharmazie 13, 468 (1958).PubMedGoogle Scholar
  26. [18b]
    Krebs: Dtsch. Apoth.-Ztg. 98, 1341 (1958).Google Scholar
  27. [19]
    Tanner, Suter, Conti und Wanner: Lebensversicher.-Med. 13, 69–71 (1961).Google Scholar

Copyright information

© Springer-Verlag OHG Berlin · Göttingen · Heidelberg 1962

Authors and Affiliations

  • E. Tanner
  • H. Suter
  • J. Conti
  • J. Wanner

There are no affiliations available

Personalised recommendations